These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 18301955)
1. Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review. Watis L; Chen SH; Chua HC; Chong SA; Sim K J Neural Transm (Vienna); 2008; 115(3):493-511. PubMed ID: 18301955 [TBL] [Abstract][Full Text] [Related]
2. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Meador-Woodruff JH; Clinton SM; Beneyto M; McCullumsmith RE Ann N Y Acad Sci; 2003 Nov; 1003():75-93. PubMed ID: 14684436 [TBL] [Abstract][Full Text] [Related]
3. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Clinton SM; Meador-Woodruff JH Schizophr Res; 2004 Aug; 69(2-3):237-53. PubMed ID: 15469196 [TBL] [Abstract][Full Text] [Related]
4. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia. Huerta I; McCullumsmith RE; Haroutunian V; Giménez-Amaya JM; Meador-Woodruff JH Synapse; 2006 Jun; 59(7):394-402. PubMed ID: 16485262 [TBL] [Abstract][Full Text] [Related]
5. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Smith RE; Haroutunian V; Davis KL; Meador-Woodruff JH Am J Psychiatry; 2001 Sep; 158(9):1393-9. PubMed ID: 11532723 [TBL] [Abstract][Full Text] [Related]
6. Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia. Smith RE; Haroutunian V; Davis KL; Meador-Woodruff JH Neuroreport; 2001 Sep; 12(13):2885-7. PubMed ID: 11588596 [TBL] [Abstract][Full Text] [Related]
7. Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ? Pratt J; Dawson N; Morris BJ; Grent-'t-Jong T; Roux F; Uhlhaas PJ Schizophr Res; 2017 Feb; 180():4-12. PubMed ID: 27317361 [TBL] [Abstract][Full Text] [Related]
8. [Role of astrocytes in alterations of glutamatergic neurotransmission in schizophrenia]. Kolomeets NS Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):110-117. PubMed ID: 25945378 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder. Clinton SM; Meador-Woodruff JH Neuropsychopharmacology; 2004 Jul; 29(7):1353-62. PubMed ID: 15054476 [TBL] [Abstract][Full Text] [Related]
10. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Kantrowitz J; Javitt DC Curr Opin Psychiatry; 2012 Mar; 25(2):96-102. PubMed ID: 22297716 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. Clinton SM; Haroutunian V; Meador-Woodruff JH J Neurochem; 2006 Aug; 98(4):1114-25. PubMed ID: 16762023 [TBL] [Abstract][Full Text] [Related]
12. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Javitt DC Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858 [TBL] [Abstract][Full Text] [Related]
13. Glutamate receptors and transporters in the hippocampus in schizophrenia. Harrison PJ; Law AJ; Eastwood SL Ann N Y Acad Sci; 2003 Nov; 1003():94-101. PubMed ID: 14684437 [TBL] [Abstract][Full Text] [Related]
14. Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Clinton SM; Haroutunian V; Davis KL; Meador-Woodruff JH Am J Psychiatry; 2003 Jun; 160(6):1100-9. PubMed ID: 12777268 [TBL] [Abstract][Full Text] [Related]
15. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Ng WX; Lau IY; Graham S; Sim K Neurosci Biobehav Rev; 2009 Mar; 33(3):336-54. PubMed ID: 18955079 [TBL] [Abstract][Full Text] [Related]
17. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Goff DC; Coyle JT Am J Psychiatry; 2001 Sep; 158(9):1367-77. PubMed ID: 11532718 [TBL] [Abstract][Full Text] [Related]
18. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Monfort P; Muñoz MD; ElAyadi A; Kosenko E; Felipo V Metab Brain Dis; 2002 Dec; 17(4):237-50. PubMed ID: 12602501 [TBL] [Abstract][Full Text] [Related]
19. Overview of Glutamatergic Dysregulation in Central Pathologies. Miladinovic T; Nashed MG; Singh G Biomolecules; 2015 Nov; 5(4):3112-41. PubMed ID: 26569330 [TBL] [Abstract][Full Text] [Related]
20. The glutamatergic dysfunction hypothesis for schizophrenia. Coyle JT Harv Rev Psychiatry; 1996; 3(5):241-53. PubMed ID: 9384954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]